Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Clearside Biomedical, Inc. (CLSD) had Free Cash Flow per Share of $-0.14 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.49M |
|
$-4.50M |
|
-- |
|
$0.49M |
|
$4.06M |
|
$-3.57M |
|
$-0.93M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$-4.50M |
|
$-3.57M |
|
$-3.48M |
|
77.84M |
|
77.84M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$11.79M |
|
$3.06M |
|
$3.55M |
|
$15.33M |
|
$3.05M |
|
-- |
|
$61.02M |
|
$64.07M |
|
$-48.73M |
|
$-48.73M |
|
$-48.73M |
|
78.50M |
|
| Cash Flow Statement Financials | |
$-10.56M |
|
$-0.01M |
|
$-0.08M |
|
$20.02M |
|
$9.38M |
|
$-10.64M |
|
$1.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-725.20% |
|
-725.20% |
|
-- |
|
-913.62% |
|
-913.62% |
|
$-10.57M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.60 |
|
149.27 |
|
9.22% |
|
9.22% |
|
-29.32% |
|
9.22% |
|
$-0.62 |
|
|
Free Cash Flow per Share |
$-0.14 |
$-0.14 |
|